BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, Goldsmith D. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol. 2013;14:24. [PMID: 23351270 DOI: 10.1186/1471-2369-14-24] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Lang E, Lang F. Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death. Biomed Res Int. 2015;2015:513518. [PMID: 25821808 DOI: 10.1155/2015/513518] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
2 Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Föller M, Lang F. Suicidal erythrocyte death in end-stage renal disease. J Mol Med (Berl) 2014;92:871-9. [PMID: 24743961 DOI: 10.1007/s00109-014-1151-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bragazzi NL, Puente GD. Chronic Kidney Disease, Spirituality and Religiosity: A Systematic Overview with the List of Eligible Studies. Health Psychol Res 2013;1:e26. [PMID: 26973911 DOI: 10.4081/hpr.2013.e26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Wang Y, Wei RB, Su TY, Huang MJ, Li P, Chen XM. Clinical and pathological factors of renal anaemia in patients with IgA nephropathy in Chinese adults: a cross-sectional study. BMJ Open 2019;9:e023479. [PMID: 30647035 DOI: 10.1136/bmjopen-2018-023479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
5 Tsai SF, Tarng DC. Anemia in patients of diabetic kidney disease. J Chin Med Assoc 2019;82:752-5. [PMID: 31453863 DOI: 10.1097/JCMA.0000000000000175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O. The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review. Int J Nephrol 2020;2020:7692376. [PMID: 32665863 DOI: 10.1155/2020/7692376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hahn D, Esezobor CI, Elserafy N, Webster AC, Hodson EM. Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients. Cochrane Database Syst Rev 2017;1:CD011690. [PMID: 28066881 DOI: 10.1002/14651858.CD011690.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrology Dialysis Transplantation 2021;36:129-36. [DOI: 10.1093/ndt/gfz192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
9 Wang H, Yang Y, Ma L, Wang X, Zhang J, Fu J, Zhang S, Zhang L, Hu D, Ding R. Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents. Sci Rep 2015;5:17213. [PMID: 26601689 DOI: 10.1038/srep17213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Tay HS, Soiza RL. Systematic review and meta-analysis: what is the evidence for oral iron supplementation in treating anaemia in elderly people? Drugs Aging 2015;32:149-58. [PMID: 25644019 DOI: 10.1007/s40266-015-0241-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
11 Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, Sarafidis PA. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World J Nephrol 2016; 5(4): 358-366 [PMID: 27458564 DOI: 10.5527/wjn.v5.i4.358] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
12 Robles NR, Ramos JL, Chavez E, Gonzalez Candia B, Bayo MA, Cidoncha A, Gomez JL, Cubero JJ. Iron deficiency in chronic kidney disease patients with diabetes mellitus. Diabetes Metab Syndr 2018;12:933-7. [PMID: 29804918 DOI: 10.1016/j.dsx.2018.05.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lang F, Jilani K, Lang E. Therapeutic potential of manipulating suicidal erythrocyte death. Expert Opin Ther Targets 2015;19:1219-27. [PMID: 26013571 DOI: 10.1517/14728222.2015.1051306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Ahmed MS, Abed M, Voelkl J, Lang F. Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol 2013;14:244. [PMID: 24188099 DOI: 10.1186/1471-2369-14-244] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
15 Soiza RL, Donaldson AIC, Myint PK. The pale evidence for treatment of iron-deficiency anaemia in older people. Ther Adv Drug Saf 2018;9:259-61. [PMID: 29854388 DOI: 10.1177/2042098618769568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Miyazaki Y, Taguchi K, Sou K, Watanabe H, Ishima Y, Miyakawa T, Mitsuya H, Fukagawa M, Otagiri M, Maruyama T. Therapeutic Impact of Erythropoietin-Encapsulated Liposomes Targeted to Bone Marrow on Renal Anemia. Mol Pharmaceutics 2014;11:4238-48. [DOI: 10.1021/mp500453a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
17 Hu X, Xie J, Chen N. Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia. Kidney Dis (Basel) 2021;7:1-9. [PMID: 33614728 DOI: 10.1159/000510587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Donaldson AIC, Soiza RL, Hands KJ, Witham MD, Myint PK. Variability in the clinical management of iron deficiency anaemia in older adults: results from a survey of UK specialists in the care of older people. Ther Adv Drug Saf 2019;10:2042098619854870. [PMID: 31223469 DOI: 10.1177/2042098619854870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nalado AM, Mahlangu JN, Waziri B, Duarte R, Paget G, Olorunfemi G, Naicker S. Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. Int J Nephrol Renovasc Dis 2019;12:19-32. [PMID: 30858723 DOI: 10.2147/IJNRD.S179802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Di Lullo L, Bellasi A, De Pascalis A. Hypertension, type IV cardiorenal syndrome and chronic kidney disease: Pathophysiological and therapeutical approach. World J Hypertens 2017; 7(1): 10-18 [DOI: 10.5494/wjh.v7.i1.10] [Reference Citation Analysis]
21 Del Vecchio L, Minutolo R. ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia? J Clin Med 2021;10:839. [PMID: 33670704 DOI: 10.3390/jcm10040839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ueda N, Takasawa K. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients 2018;10:E1173. [PMID: 30150549 DOI: 10.3390/nu10091173] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
23 Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S. Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian J Endocrinol Metab 2016;20:268-81. [PMID: 27042425 DOI: 10.4103/2230-8210.176348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Minutolo R, Berto P, Liberti ME, Peruzzu N, Borrelli S, Netti A, Garofalo C, Conte G, De Nicola L, Del Vecchio L, Locatelli F. Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study. J Clin Med 2021;10:1322. [PMID: 33806864 DOI: 10.3390/jcm10061322] [Reference Citation Analysis]
25 Ronco C, Di Lullo L. Cardiorenal syndrome. Heart Fail Clin. 2014;10:251-280. [PMID: 24656104 DOI: 10.1016/j.hfc.2013.12.003] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 10.5] [Reference Citation Analysis]
26 Idris I, Tohid H, Muhammad NA, A Rashid MR, Mohd Ahad A, Ali N, Sharifuddin N, Aris JH. Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study. BMJ Open 2018;8:e025125. [PMID: 30580276 DOI: 10.1136/bmjopen-2018-025125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
27 Lang F, Abed M, Lang E, Föller M. Oxidative stress and suicidal erythrocyte death. Antioxid Redox Signal 2014;21:138-53. [PMID: 24359125 DOI: 10.1089/ars.2013.5747] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 9.1] [Reference Citation Analysis]